Eran Benjamin, PhDGlobal Director, Analytical Development and Quality at PolyPeptide GroupSpeaker
Profile
Eran J. Benjamin received his doctorate in Organic Chemistry with Prof. Mati Fridkin at the Weizmann Institute of Science and is currently the Global Director of Quality Control and Analytical Development at the PolyPeptide Group, based in Torrance CA. Prior to joining Polypeptide, Eran was a Principal Research Sceintist at Eli Lilly and Company in the development and commercialization of Insulins and Peptide-based therapeutics and was the Director of characterization science and small molecule analytical development.
Agenda Sessions
Tailoring Control Strategies to Meet Specific Peptide Drug Substance Complexity, Customer Needs and Regulatory Requirements
, 2:30pmView Session